Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This is an exploratory proof-of-concept study to evaluate the safety and efficacy of
canakinumab (ACZ885) for inflammation and pain associated with acute gouty arthritis.